1. Stocks
  2. ARS Pharmaceuticals Inc
  3. Swot
swot-logo

ARS Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

ARS Pharmaceuticals Inc has 20 Strengths, 6 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

High Normalized Momentum Score

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Near 52 Week High

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Companies with Low Debt

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Momentum Trap (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low durability companies

Top Losers

Profit to Loss Companies

Top Losers

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months